334 related articles for article (PubMed ID: 32370480)
21. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography].
Faber L; Seggewiss H; Fassbender D; Bogunovic N; Strick S; Schmidt HK; Gleichmann U
Z Kardiol; 1998 Mar; 87(3):191-201. PubMed ID: 9586154
[TBL] [Abstract][Full Text] [Related]
22. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience.
Kuhn H; Lawrenz T; Lieder F; Leuner C; Strunk-Mueller C; Obergassel L; Bartelsmeier M; Stellbrink C
Clin Res Cardiol; 2008 Apr; 97(4):234-43. PubMed ID: 18071624
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous transluminal septal myocardial ablation: past, present, and future.
Maekawa Y; Takamisawa I; Takano H; Takayama M
J Cardiol; 2022 Sep; 80(3):211-217. PubMed ID: 34924238
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
Seggewiss H; Faber L; Gleichmann U
Thorac Cardiovasc Surg; 1999 Apr; 47(2):94-100. PubMed ID: 10363608
[TBL] [Abstract][Full Text] [Related]
25. Is There a Role for Alcohol Septal Ablation in Young Patients with Medically Refractory Hypertrophic Obstructive Cardiomyopathy?
Sivakumar K; Jain G
Pediatr Cardiol; 2024 Mar; 45(3):648-659. PubMed ID: 36995405
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients.
Faber L; Meissner A; Ziemssen P; Seggewiss H
Heart; 2000 Mar; 83(3):326-31. PubMed ID: 10677415
[TBL] [Abstract][Full Text] [Related]
27. Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy.
Kurita T; Tsuchikane E; Tanaka N; Suzuki T
Cardiovasc Interv Ther; 2015 Oct; 30(4):377-81. PubMed ID: 25502014
[TBL] [Abstract][Full Text] [Related]
28. Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy.
Cavigli L; Fumagalli C; Maurizi N; Rossi A; Arretini A; Targetti M; Passantino S; Girolami F; Tomberli B; Baldini K; Tomberli A; Antoniucci D; Yacoub MH; Marchionni N; Stefano PL; Cecchi F; Olivotto I
Int J Cardiol; 2018 Dec; 273():155-161. PubMed ID: 30213605
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Significance of Initial r-Wave in Leads V1 and aVR Before PTSMA in Patients with Hypertrophic Obstructive Cardiomyopathy.
Jiang X; Qiao S
Int J Gen Med; 2021; 14():9589-9598. PubMed ID: 34916839
[TBL] [Abstract][Full Text] [Related]
30. Predictors of long-term outcome after septal myectomy in symptomatic hypertrophic obstructive cardiomyopathy patients with previous alcohol septal ablation and residual obstruction.
Zhu C; Tang B; Cui H; Wang S; Xiao M; Chen Z; Meng Y; Zhao S; Song Y; Yu Q; Wang S
J Card Surg; 2019 Jul; 34(7):533-540. PubMed ID: 31111576
[TBL] [Abstract][Full Text] [Related]
31. MR imaging evaluation of regional, remote, and global effects of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
Amano Y; Takayama M; Kumita S; Kumazaki T
J Comput Assist Tomogr; 2007; 31(4):600-4. PubMed ID: 17882040
[TBL] [Abstract][Full Text] [Related]
32. [Role of cardiac magnetic resonance on predicting outcome in patients with hypertrophic obstructive cardiomyopathy undergoing percutaneous transluminal septal myocardial ablation].
Du H; Lu M; Yin G; Yin X; Jiang Y; Wang J; Chen X; Song L; Huang J; Zhang Y; Zhao S
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Aug; 42(8):665-9. PubMed ID: 25388340
[TBL] [Abstract][Full Text] [Related]
33. Long term exercise capacity in patients with hypertrophic cardiomyopathy treated with percutaneous transluminal septal myocardial ablation.
Malek LA; Chojnowska L; Klopotowski M; Maczynska R; Demkow M; Witkowski A; Kusmierczyk B; Piotrowicz E; Konka M; Dabrowski M; Ruzyllo W
Eur J Heart Fail; 2008 Nov; 10(11):1123-6. PubMed ID: 18840395
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy through non-left anterior descending septal perforators.
Imori Y; Takano H; Kitamura M; Aoyama R; Sangen H; Kenta O; Matsuda J; Kubota Y; Tokita Y; Yamamoto T; Asai K; Takayama M; Shimizu W
Heart Vessels; 2020 May; 35(5):647-654. PubMed ID: 31641886
[TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance imaging of microvascular obstruction in hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation.
Amano Y; Kitamura M; Yamada F; Aita K; Takayama M; Tachi M; Kumita S
Acta Radiol; 2015 Nov; 56(11):1323-8. PubMed ID: 25414371
[TBL] [Abstract][Full Text] [Related]
36. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Australian Single Centre Experience.
Nogic J; Koh Y; Bak M; Gooley RP; Meredith IT; McCormick LM
Heart Lung Circ; 2018 Dec; 27(12):1446-1453. PubMed ID: 29129561
[TBL] [Abstract][Full Text] [Related]
37. [Non-drug treatment for hypertrophic obstructive cardiomyopathy in children].
Zhang X; Li YF; Xie B; Chen JY; Qian MY
Zhonghua Er Ke Za Zhi; 2011 May; 49(5):381-5. PubMed ID: 21624293
[TBL] [Abstract][Full Text] [Related]
38. Reverse remodeling after percutaneous transluminal septal myocardial ablation in severe but asymptomatic LVOT obstruction (RASTA) study: Rationale and design of transcatheter septal reduction in asymptomatic patients with severe hypertrophic obstructive cardiomyopathy.
Arslan F; Akdim F; Ten Berg JM
Catheter Cardiovasc Interv; 2021 Feb; 97(3):488-492. PubMed ID: 32808736
[TBL] [Abstract][Full Text] [Related]
39. Does ablation of atrial fibrillation at the time of septal myectomy improve survival of patients with obstructive hypertrophic cardiomyopathy?
Cui H; Schaff HV; Dearani JA; Lahr BD; Viehman JK; Geske JB; Nishimura RA; Ommen SR
J Thorac Cardiovasc Surg; 2021 Mar; 161(3):997-1006.e3. PubMed ID: 32977972
[TBL] [Abstract][Full Text] [Related]
40. [Myocardial perfusion evaluation post percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy by ⁹⁹Tc(m) MIBI SPECT MPI].
Sun XX; Tian YQ; Qiao SB; Yuan JS; Duan FJ; Wang DY; Guo F; He ZX
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jun; 39(6):497-502. PubMed ID: 21924073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]